Melanoma treatment in review B Domingues, JM Lopes, P Soares, H Pópulo ImmunoTargets and therapy 7, 35, 2018 | 726 | 2018 |
Future directions for ureteral stent technology: from bench to the market B Domingues, M Pacheco, JE de la Cruz, I Carmagnola, ... Advanced Therapeutics 5 (1), 2100158, 2022 | 11 | 2022 |
Bioinks enriched with ECM components obtained by supercritical extraction DP Reis, B Domingues, C Fidalgo, RL Reis, L Gasperini, AP Marques Biomolecules 12 (3), 394, 2022 | 7 | 2022 |
Helena Pópulo B Domingues, JM Lopes, P Soares Melanoma treatment in review. Immunotargets Ther 7, 35-49, 2018 | 7 | 2018 |
Coatings for Urinary Stents: Current State and Future Directions B Domingues, JM Silva, IM Aroso, E Lima, AA Barros, RL Reis Urinary Stents: Current State and Future Perspectives, 209-223, 2022 | 4 | 2022 |
Combinatorial therapies to overcome BRAF/MEK inhibitors resistance in melanoma cells: an in vitro study H Pópulo, B Domingues, C Sampaio, JM Lopes, P Soares Journal of experimental pharmacology, 521-535, 2021 | 4 | 2021 |
Hydrogels as stents M Pacheco, B Domingues, E Lima, RL Reis, A Barros Hydrogels for Tissue Engineering and Regenerative Medicine, 467-482, 2024 | | 2024 |
Biodegradable and electrically responsive polymer hydrogel as a drug delivery system to manage ureteral stent-associated pain B Domingues, E Silva, E Lima, AA Barros, RL Reis TISSUE ENGINEERING PART A 29 (13-14), 2023 | | 2023 |
Internal and external metal-based coatings to prevent uropathogen adhesion on stents B Domingues, IM Aroso, E Lima, A Barros, RL Reis EUROPEAN UROLOGY 79, S197-S198, 2021 | | 2021 |
Metabolic modulation combined with mTOR pathway inhibition may overcame cutaneous melanoma resistance to MAPK inhibitors treatment C Sampaio, B Domingues, P Soares, JM Lopes, H Pópulo European Journal of Cancer 138, S23, 2020 | | 2020 |
Method of post-manufacture impregnation to create a drug-eluting stent - ENIUS. European Network of multidisciplinary research to Improve the Urinary Stents. COSTS Actions … B Domingues, IM Aroso, E Lima, AA Barros, RL Reis Urolithiasis 48, 553–559, 2020 | | 2020 |
Possible therapies to overcome resistance to MAPK inhibitors in mutant BRAF melanoma BB Domingues | | 2018 |